Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...

John F. Kennedy’s granddaughter has disclosed that she has terminal cancer, writing in an essay in “The New Yorker” on ...

Why are vaccines so hard to make? The fda approved two mRNA vaccines for COVID-19, but it was a challenge to make this type ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer's mRNA flu vaccine posts promising NEJM results. Dr. Todd Ellerin of South Shore Health discusses safety, side effects ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Scientists are increasingly looking at mRNA vaccines for cancer, not just viruses. The results of a study published in the journal Nature in October showed the promise of mRNA vaccines in fighting ...

There are few more divisive issues in medicine today than the topic of vaccines. Until COVID, most Americans were glad to have their children vaccinated against measles, mumps, rubella, polio, HepB, ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...